27. 50
CHF 0
0%
159.07M Market Cap
- P/E Ratio
- Div Yield
2,367 Volume
- Eps
27.5 CHF
Previous Close Want to track BIOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BioVersys AG (BIOV) Statistics
Valuation metrics
Market Cap 159.07M
Enterprise value 98.29M
Trailing P/E (ttm) -6.92
Forward P/E -4.57
PEG ratio -4.57
Price/Sales (ttm) 49.55
Price/Book (mrq) 2.63
Enterprise Value/Revenue 30.96
Enterprise Value/EBITDA -4.94
Overview
Shares outstanding 5.85M
Float 4.29M
Shares short -
% Held by insiders 0.34%
% Held by institutions 0.13%
Average volume (10 days) 803
Average volume (90 days) 1.16K
Price summary
52-Week low 21.2
52-Week high 33.9
Beta -
50-Day moving average 27.78
200-Day moving average 26.04
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -3.87%
Operating margin -4.06%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.62%
Income Statement
Revenue (ttm) 3.17M
Revenue per share (ttm) 0.56
Quarterly revenue growth (yoy) 2.52%
Gross profit (ttm) 3.17M
EBITDA -19.89M
Net income to common (ttm) -21.83M
Diluted EPS (ttm) -3.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 82.5M
Total cash per share (mrq) 14.11
Total debt (mrq) 21.73M
Total Debt/Equity (mrq) 36.33
Current ratio (mrq) 10.1%
Book value per share (mrq) 10.23
Cash Flow
Cash flow statement -21.95M
Levered free cash flow (LFCF) -15.86M
